Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$10.2M Sell
248,154
-137,396
-36% -$5.17M 7.5% 6
2021
Q3
$13.3M Buy
+385,550
New +$13.2M 19.17% 2
2020
Q1
Sell
-579,026
Closed -$18.8M 17
2019
Q4
$18.8M Buy
579,026
+347,696
+150% +$11.3M 8.69% 6
2019
Q3
$7.97M Buy
+231,330
New +$7.77M 6.71% 6
2019
Q2
Sell
-632,903
Closed -$22.6M 15
2019
Q1
$22.6M Buy
+632,903
New +$21.6M 13.22% 3
2018
Q4
Sell
-483,690
Closed -$15.1M 7
2018
Q3
$15.1M Buy
+483,690
New +$14.9M 12.21% 4
2017
Q1
Sell
-378,540
Closed -$9.58M 37
2016
Q4
$9.58M Sell
378,540
-3,285,293
-90% -$77.9M 1.28% 21
2016
Q3
$87M Sell
3,663,833
-264,800
-7% -$6.65M 8.89% 4
2016
Q2
$102M Buy
3,928,633
+1,682,243
+75% +$41.6M 16.06% 1
2016
Q1
$57.5M Sell
2,246,390
-502,315
-18% -$11.3M 8.68% 4
2015
Q4
$54.4M Buy
+2,748,705
New +$55.7M 10.48% 3

Other funds holding EXC

LNZ Capital's EXC Position: Q4 2021 in Review

LNZ Capital reduced its Exelon (EXC) stake by 36% in Q4 2021, selling an estimated $5.17M and leaving 248,154 shares worth $10.2M. The position accounts for 7.5% of the portfolio, ranked #6.

LNZ Capital first reported a position in EXC in Q4 2015 and has held it in 11 quarters since. The position peaked at $102M in Q2 2016. 1,069 funds tracked by Wall St. Rank hold EXC as of Q4 2021.

  • LNZ Capital held 248,154 shares of Exelon worth $10.2M as of Q4 2021.
  • LNZ Capital sold 137,396 Exelon shares in Q4 2021, an estimated $5.17M.
  • Exelon made up 7.5% of LNZ Capital's portfolio in Q4 2021, its #6 holding.
  • LNZ Capital first reported a position in Exelon in Q4 2015 and has held it in 11 quarters since.
  • LNZ Capital's Exelon position peaked at $102M in Q2 2016.
  • 1,069 funds tracked by Wall St. Rank held Exelon as of Q4 2021.

Based on LNZ Capital's 13F filing for Q4 2021, filed 14 Feb 2022.